Aston Medical School Secures Landmark NIHR Funding for 12 New Clinical Fellows

Aston Medical School has secured a major success in its mission to combine frontline care with research excellence. The school has been awarded funding from the National Institute for Health and Care Research (NIHR) for 12 new Academic Clinical Fellowships, competitive posts designed to train the next generation of clinician-scientists. These early career doctors will split their time between patient care in the NHS and conducting cutting-edge research at Aston University.

The successful bid was led by Dr Zaki Hassan Smith, clinical associate professor at Aston Medical School, who highlighted the significance of the award for both Aston and the wider region. “Securing 12 new NIHR Academic Clinical Fellow posts is a landmark moment for Aston Medical School. It reflects the strength of our partnerships with the NHS and our commitment to developing the next generation of clinician-scientists. These posts will enable us to nurture talented doctors who will not only deliver outstanding patient care but also lead pioneering research that tackles the most pressing health challenges of our time.”

The posts last for three to four years depending on speciality and are highly competitive, attracting doctors who want to combine postgraduate clinical training with research. Known as NIHR Academic Clinical Fellows, they work at the interface of patient care and academic enquiry. At Aston, the Fellows will be embedded in local NHS hospitals, where they will carry out real-world research alongside their clinical duties. Their work will be supported by Aston’s research infrastructure, including the Institute of Health and Neurodevelopment (IHN), the Aston Research Centre for Health in Ageing (ARCHA), and the Aston Centre for Artificial Intelligence Research and Application (ACAIRA), which applies AI to health challenges.

This latest success builds on Aston’s track record. In 2023, the Medical School secured 12 NIHR Fellows who are already conducting research across areas such as endocrinology, neurology, clinical genetics, paediatrics, trauma and orthopaedics, psychiatry, and general practice. The new Fellows will extend this scope further, bringing additional expertise into fields including clinical genetics and genomics, trauma and orthopaedics, obstetrics and gynaecology, and digital health.

The inclusion of digital health as a focus reflects a wider shift in the way research and practice are evolving. Digital health is an emerging field that harnesses artificial intelligence and data science to improve outcomes, support clinical decision-making and streamline healthcare delivery. AI-based tools have the potential to analyse vast datasets, uncovering patterns that could allow for earlier disease detection and better resource allocation. With global health systems under increasing strain, these data-driven solutions are becoming essential to delivering sustainable and effective care.

Other projects that will be carried out by the new Fellows reflect the breadth of Aston’s ambition and its alignment with major health challenges. These include investigating the impact of weight loss medications on reducing multi-morbidity, exploring the biological mechanisms of muscle wasting with ageing and metabolic disease, optimising medications for patients with severe mental health conditions, and advancing understanding of neurological diseases such as epilepsy and multiple sclerosis. By tackling these diverse questions, the Fellows will be contributing to fields that have immediate and long-term importance for both patients and health systems.

For Aston Medical School, which is still in its early years, the award is particularly significant. Dr Hassan Smith underlined this in his reflections on the announcement. “For Aston, this represents both recognition of our rapid progress as a new medical school and an exciting opportunity to shape the future of clinical academia in the UK.” The combination of clinical experience, academic training and exposure to innovative research environments is intended to produce a generation of clinician-scientists who are equally skilled in the consulting room and the laboratory.

The benefits of this approach extend beyond Aston itself. By working directly with local NHS trusts and within Birmingham’s wider health ecosystem, the Fellows’ research is grounded in the real-world challenges faced by patients and clinicians in the region. This ensures that their findings are not only academically robust but also practically relevant, offering insights and solutions that can be translated into practice. It also strengthens Aston’s collaboration with NHS England and reinforces the university’s role as a partner in addressing both local and national health priorities.

As recruitment for the new Fellows begins in the autumn, Aston is positioning itself as a centre of excellence for nurturing clinician-scientists. The expansion of its NIHR Fellow cohort from 12 to 24 in just two years reflects both the ambition of the school and the confidence placed in it by national funders. With Fellows addressing questions from genetics and ageing to digital health and neurological disease, the breadth of research underway illustrates the contribution that Aston Medical School is making to the advancement of healthcare knowledge and practice.

The award also demonstrates how universities and health systems can work together to train doctors who are not only effective practitioners but also innovators capable of leading the next wave of medical progress. In a time of global health challenges, this dual expertise is increasingly necessary. By embedding research within clinical training, Aston Medical School is helping to ensure that future doctors are equipped not just to treat patients but to transform the way medicine is practised.

Read the original: https://www.greaterbirminghamchambers.com/resource/medical-school-wins-12-nihr-fellowships-to-advance-cutting-edge-research.html?utm_campaign=EMAIL_CLD_260825&utm_medium=email

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Paul Cadman | Executive Chairman | WM Life Sciences

Prof Paul Cadman

CEO of One Thousand Trades Group & Co-founder of Life Sciences Week,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Prof. Paul Cadman is a nationally and internationally recognised, award-winning inclusive leader and “knowledge broker”, known for bringing people, ideas and organisations together to turn ambition into deliverable outcomes.

His experience spans Research, Technology, Manufacturing, Consultancy and Membership Organisations – giving him a rare ability to translate between sectors, priorities and professional cultures in a way that builds trust and unlocks progress.

Across his career, Paul has helped take concepts from inception through to scale, including initiatives that have generated £100m+ in turnover. He combines strategic thinking with an extensive network, supporting organisations to drive organic growth, forge partnerships and deliver meaningful business transformation. He is particularly valued for his ability to connect the right stakeholders at the right time, and create the conditions for collaboration to become action.

Through Life Sciences Week, Paul helps convene the communities shaping innovation – bringing together research, industry and investment to strengthen relationships, spotlight opportunity, and accelerate real-world impact.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details